Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in LQDA — Liquidia Corp

CIK 861177 NEW YORK, NY

Position in LQDA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,719,959
+$5,318,951 QoQ
Shares Held
121,911
+4.5% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 334 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 34% Shared 0% None 66%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. LQDA ranks #9 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LQDA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,719,959 121,911
2026-03-31 $4,401,008 116,614
2025-12-31 $5,078,856 147,256
2025-09-30 $3,486,381 153,315
2025-06-30 $596,784 47,896
2025-03-31 $1,795,901 121,756
2024-12-31 $1,243,431 105,734
2024-09-30 $832,890 83,289
2024-06-30 $1,051,800 87,650
2024-03-31 $169,625 11,500